These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2849728)

  • 1. Histidine abolishes the inhibition by zinc of naloxone binding to opioid receptors in rat brain.
    Hanissian SH; Tejwani GA
    Neuropharmacology; 1988 Nov; 27(11):1145-9. PubMed ID: 2849728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of mu, delta and kappa opioid receptors in rat brain by metal ions and histidine.
    Tejwani GA; Hanissian SH
    Neuropharmacology; 1990 May; 29(5):445-52. PubMed ID: 2162496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain.
    Rosati AM; Traversa U
    Biochem Pharmacol; 1999 Aug; 58(4):623-32. PubMed ID: 10413299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors.
    Oktem HA; Apaydin S
    Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analogue of thyrotropin-releasing hormone, DN1417, decreases naloxone binding in the rat brain.
    Mori M; Michimata T; Ishihara H; Yamada M; Iriuchijima T; Kobayashi S
    Proc Soc Exp Biol Med; 1989 Oct; 192(1):6-10. PubMed ID: 2552454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine-induced changes in 3H-naloxone binding in brain membranes isolated from spontaneously hypertensive and Wistar-Kyoto rats.
    Ishizuka Y; Rockhold RW; Hoskins B; Ho IK
    Life Sci; 1988; 43(26):2275-82. PubMed ID: 2850430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of mu, kappa and delta opioid receptors in the rat brain by isoflurane and enflurane.
    Tejwani GA; Rattan AK; Gudehithlu KP; McDonald JS
    Neuropharmacology; 1991 Jun; 30(6):643-9. PubMed ID: 1656304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opiate receptor binding of naloxone in the rat brain: effect of sodium ions].
    Balashov AM; Petrichenko OB; Aliab'eva TN; Panchenko LF
    Biokhimiia; 1988 Sep; 53(9):1527-31. PubMed ID: 2849481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of opiate receptor binding by zinc ions: possible physiological importance in the hippocampus.
    Stengaard-Pedersen K; Fredens K; Larsson LI
    Peptides; 1981; 2 Suppl 1():27-35. PubMed ID: 6267559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
    Gulya K; Lui GK; Pelton JT; Kazmierski W; Hruby VJ; Yamamura HI
    NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo binding of naloxone to opioid receptors in morphine-dependent mice.
    Oishi R; Ozaki M; Takemori AE
    Neuropharmacology; 1983 Aug; 22(8):1015-9. PubMed ID: 6312358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed analysis of heterogeneity of [3H]naloxone binding sites in rat brain synaptosomes.
    Szücs M; Borsodi A; Bogdány A; Gaál J; Batke J; Tóth G
    Neurochem Res; 1987 Jul; 12(7):581-7. PubMed ID: 3039389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium ions modulate differentially the effect of a benzodiazepine agonist on rat spinal mu-, delta- and kappa-opioid receptors.
    Rattan AK; Tejwani GA
    Pharmacology; 1994 Jan; 48(1):30-40. PubMed ID: 8309985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of guanine nucleotides, transition metals and temperature on enkephalin receptors of rat brain membranes.
    Ogawa N; Mizuno S; Fukushima M; Mori A
    Peptides; 1985; 6 Suppl 1():23-8. PubMed ID: 2995942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of eptazocine, a novel analgesic, with opioid receptors.
    Nabeshima T; Matsuno K; Kamei H; Kameyama T
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):173-81. PubMed ID: 2992058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear [3H]naloxone binding in rat hypothalamus.
    Vértes Z; Környei JL; Kovács S; Vértes M
    Neuroreport; 1995 Nov; 6(17):2385-8. PubMed ID: 8747159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergot alkaloids inhibit 3H-naloxone binding to opiate receptors in the rat striatum and hippocampus.
    Kosar E; Sumová A; Jakoubek B
    Physiol Bohemoslov; 1986; 35(4):334-9. PubMed ID: 3020603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.